Watchlist Price Alert

Aptevo Therapeutics Inc. (APVO)

NASDAQ: APVO · Real-Time Price · USD

3.12

-0.54 (-14.75%)

At close: Jun 17, 2025, 1:51 PM

Aptevo Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Cash & Equivalents	8.71M	16.9M	22.64M	45.04M	39.98M	12.45M	30.64M	7.09M	9.68M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	73.69M	44.85M
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	7.5M	7.45M	-17.37M	n/a
Other Long-Term Assets	n/a	n/a	-6.76M	68K	746K	11.3M	8.35M	10M	n/a
Receivables	n/a	n/a	2.5M	3.66M	2.37M	n/a	5.22M	2.14M	307K
Inventory	n/a	n/a	1.57M	3.08M	4.78M	6.14M	1.78M	1.03M	6.64M
Other Current Assets	256K	689K	744K	2.04M	2.69M	10.33M	4.14M	7.11M	12.58M
Total Current Assets	10.66M	19.07M	27.45M	52.57M	47.26M	30M	48.69M	95.08M	71.41M
Property-Plant & Equipment	4.93M	5.78M	6.76M	3.96M	5.54M	7.69M	5.2M	5.84M	5.91M
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	4.42M	5.25M	6.08M	14.53M
Total Long-Term Assets	4.93M	5.78M	6.76M	4.03M	6.28M	23.41M	18.8M	21.92M	20.44M
Total Assets	15.59M	24.84M	34.22M	56.6M	53.55M	53.41M	67.49M	117.01M	91.86M
Account Payables	n/a	3.98M	3.5M	3.46M	5.58M	6.43M	11.67M	7.35M	10.52M
Deferred Revenue	n/a	n/a	-3.5M	-3.46M	-5.58M	-3.75M	n/a	-7.35M	811K
Short-Term Debt	n/a	n/a	2M	11.67M	5M	19.86M	n/a	3.33M	n/a
Other Current Liabilities	6.21M	1.14M	1.1M	17.55M	1.2M	9.08M	2.04M	3.2M	4.21M
Total Current Liabilities	6.21M	7.22M	8.71M	34.76M	14.54M	38.24M	17.61M	18.51M	19.54M
Long-Term Debt	4.63M	n/a	1.46M	3.71M	20.05M	n/a	19.28M	15.73M	18.38M
Other Long-Term Liabilities	n/a	n/a	n/a	15.58M	n/a	n/a	200K	734K	469K
Total Long-Term Liabilities	4.63M	5.4M	7.54M	20.63M	22.41M	3.33M	19.48M	16.46M	21.75M
Total Liabilities	10.84M	12.62M	16.24M	55.38M	36.95M	41.57M	37.09M	34.97M	41.29M
Total Debt	4.63M	5.4M	9.54M	16.71M	27.41M	23.19M	19.28M	19.06M	18.38M
Common Stock	84K	61K	48K	47K	46K	45K	23K	22K	20K
Retained Earnings	-247.58M	-223.45M	-206.04M	-214.06M	-185.61M	-167.86M	-127.41M	-73.72M	-80.69M
Comprehensive Income	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-105K	-33K
Shareholders Equity	4.75M	12.22M	17.97M	1.22M	16.59M	11.84M	30.41M	82.03M	50.57M
Total Investments	n/a	n/a	n/a	n/a	n/a	7.5M	7.45M	73.69M	44.85M